CNK Stock Analysis: Cinemark Holdings | NYSE
Entertainment | NYSE, USA | Market Cap: 4.242m USD | 12M Return: 48.7% | US17243V1026 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 91.0M
EPS Trend: 28.6%
Qual. Beats: 0
Rev. Trend: 69.2%
Qual. Beats: 1
Warnings
Tailwinds
Seasonality 11.6 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Cinemark Holdings, Inc. (NYSE: CNK) is a theatrical exhibition company that operates movie theatres across the United States and Latin America. Founded in 1984 and headquartered in Plano, Texas, the company has been publicly traded since its April 2007 IPO.
Classified within the Movies & Entertainment sub-industry of the Communication Services sector, Cinemark operates a capital-intensive business model that generates revenue primarily through box office ticket sales and food and beverage concessions. Its results are closely tied to film release schedules, seasonal attendance patterns, and consumer discretionary spending on out-of-home entertainment.
- Box office recovery hinges on summer blockbuster slate quality
- Latin American operations drive international segment revenue growth
- Concession margins expand as theatrical attendance rebounds post-pandemic
| Net Income: 216.0m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.05 > 0.02 and ΔFCF/TA -1.24 > 1.0 |
| NWC/Revenue: -5.88% < 20% (prev 13.45%; Δ -19.33% < -1%) |
| CFO/TA 0.09 > 3% & CFO 579.0m > Net Income 216.0m |
| Net Debt (2.50b) to EBITDA (607.8m): 4.11 < 3 |
| Current Ratio: 0.78 > 1.5 & < 3 |
| Outstanding Shares: last quarter (116.6m) vs 12m ago -21.80% < -2% |
| Gross Margin: 29.98% > 18% (prev 64.08%; Δ -34.10% > 0.5%) |
| Asset Turnover: 58.90% > 50% (prev 64.51%; Δ -5.60% > 0%) |
| Interest Coverage Ratio: 2.85 > 6 (EBIT TTM 401.6m / Interest Expense TTM 141.0m) |
| A: -0.03 (Total Current Assets 703.2m - Total Current Liabilities 901.0m) / Total Assets 6.43b |
| B: 0.01 (Retained Earnings 47.1m / Total Assets 6.43b) |
| C: 0.07 (EBIT TTM 401.6m / Avg Total Assets 5.71b) |
| D: 0.47 (Book Value of Equity 2.06b / Total Liabilities 4.36b) |
| Altman-Z'' = 0.79 = B |
| DSRI: 1.21 (Receivables 286.9m/226.9m, Revenue 3.36b/3.22b) |
| GMI: 2.14 (GM 64.08% / 29.98%) |
| AQI: 2.09 (AQ_t 0.71 / AQ_t-1 0.34) |
| SGI: 1.05 (Revenue 3.36b / 3.22b) |
| TATA: -0.06 (NI 216.0m - CFO 579.0m) / TA 6.43b) |
| Beneish M = -1.15 (Cap -4..+1) = D |
As of August 25, 2026, the stock is trading at USD 38.40 with a total of 2,797,514 shares traded. Over the past week, the price has changed by +2.35%, over one month by +17.40%, over three months by +41.13% and over the past year by +48.69%.
Current recommended Stop Loss: 36.90 (which is 3.9% or 1.3 ATR below the current price).
Cinemark Holdings has received a consensus analysts rating of 3.90. Therefore, it is recommended to buy CNK.
- StrongBuy: 3
- Buy: 4
- Hold: 2
- Sell: 1
- StrongSell: 0
| Analysts Target Price | 39.3 | 2.3% |
P/E Trailing = 20.4469
P/E Forward = 16.3399
P/S = 1.2614
P/B = 8.5584
P/EG = 1.7222
Revenue TTM = 3.36b USD
EBIT TTM = 401.6m USD
EBITDA TTM = 607.8m USD
Long Term Debt = 1.87b USD (from longTermDebt, last quarter)
Short Term Debt = 191.1m USD (from shortTermDebt, last quarter)
Debt = 3.00b USD (from shortLongTermDebtTotal, last quarter) + Leases 1.09b
Net Debt = 2.50b USD (calculated: Debt 3.00b - CCE 504.3m)
Enterprise Value = 6.74b USD (4.24b + Debt 3.00b - CCE 504.3m)
Interest Coverage Ratio = 2.85 (Ebit TTM 401.6m / Interest Expense TTM 141.0m)
EV/FCF = 21.53x (Enterprise Value 6.74b / FCF TTM 313.0m)
FCF Yield = 4.65% (FCF TTM 313.0m / Enterprise Value 6.74b)
FCF Margin = 9.31% (FCF TTM 313.0m / Revenue TTM 3.36b)
Net Margin = 6.42% (Net Income TTM 216.0m / Revenue TTM 3.36b)
Gross Margin = 29.98% ((Revenue TTM 3.36b - Cost of Revenue TTM 2.35b) / Revenue TTM)
Gross Margin QoQ = 51.26% (prev 20.98%)
Tobins Q-Ratio = 1.05 (Enterprise Value 6.74b / Total Assets 6.43b)
Interest Expense / Debt = 4.70% (Interest Expense 141.0m / Debt 3.00b)
Taxrate = 16.32% (43.0m / 263.4m)
NOPAT = 336.0m (EBIT 401.6m * (1 - 16.32%))
Current Ratio = 0.78 (Total Current Assets 703.2m / Total Current Liabilities 901.0m)
Debt / Equity = 1.46 (Debt 3.00b / totalStockholderEquity, last quarter 2.06b)
Debt / EBITDA = 4.11 (Net Debt 2.50b / EBITDA 607.8m)
Debt / FCF = 7.97 (Net Debt 2.50b / FCF TTM 313.0m)
Total Stockholder Equity = 807.1m (last 4 quarters mean from totalStockholderEquity)
RoA = 3.78% (Net Income 216.0m / Total Assets 6.43b)
RoE = 26.76% (Net Income TTM 216.0m / Total Stockholder Equity 807.1m)
RoCE = 15.00% (EBIT 401.6m / Capital Employed (Equity 807.1m + L.T.Debt 1.87b))
RoIC = 6.05% (NOPAT 336.0m / Invested Capital 5.55b)
WACC = 4.76% (E(4.24b)/V(7.24b) * Re(5.35%) + D(3.00b)/V(7.24b) * Rd(4.70%) * (1-Tc(0.16)))
Discount Rate = 5.35% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -81.40 | Cagr: -11.22%
[DCF] Terminal Value 75.79% ; FCFF base≈309.7m ; Y1≈318.0m ; Y5≈352.0m
[DCF] Fair Price = 25.49 (EV 5.45b - Net Debt 2.50b = Equity 2.95b / Shares 115.9m; r=8.35% [WACC [floored]]; 5y FCF grow 2.69% → 2.50% )
EPS Correlation: 28.60 | EPS CAGR: 12.26% | SUE: 0.66 | # QB: 0
Revenue Correlation: 69.20 | Revenue CAGR: 3.76% | SUE: 3.70 | # QB: 1
EPS current Quarter (2026-09-30): EPS=0.68 | Chg30d=-10.75% | Revisions=-38% | Analysts=9
EPS current Year (2026-12-31): EPS=2.35 | Chg30d=+7.46% | Revisions=+44% | GrowthEPS=+125.8% | GrowthRev=+13.7%
EPS next Year (2027-12-31): EPS=2.66 | Chg30d=+8.35% | Revisions=+67% | GrowthEPS=+13.4% | GrowthRev=+3.4%
[Analyst] Revisions Ratio: +35% (up=12, down=5)